Terms: = Uterine cancer AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
9 results:
1. LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing fus-mediated degradation of ABHD11 mRNA.
Yang T; Tian S; Zhao J; Pei M; Zhao M; Yang X
Cell Cycle; 2023; 22(23-24):2538-2551. PubMed ID: 38146687
[TBL] [Abstract] [Full Text] [Related]
2. Relationship and prognostic significance of IL-33, PD-1/PD-L1, and tertiary lymphoid structures in cervical cancer.
Zhang Y; Li J; Yang F; Zhang X; Ren X; Wei F
J Leukoc Biol; 2022 Dec; 112(6):1591-1603. PubMed ID: 35501298
[TBL] [Abstract] [Full Text] [Related]
3. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients.
Horeweg N; Workel HH; Loiero D; Church DN; Vermij L; Léon-Castillo A; Krog RT; de Boer SM; Nout RA; Powell ME; Mileshkin LR; MacKay H; Leary A; Singh N; Jürgenliemk-Schulz IM; Smit VTHBM; Creutzberg CL; Koelzer VH; Nijman HW; Bosse T; de Bruyn M;
Nat Commun; 2022 Mar; 13(1):1373. PubMed ID: 35296668
[TBL] [Abstract] [Full Text] [Related]
4. The Prognostic Significance of Peritumoral Lymphocytes' Band-like Structure in Type II Endometrial cancer.
Shimizu Y; Suzuki S; Ukai M; Hattori S; Yoshikawa N; Kajiyama H
Anticancer Res; 2021 Jan; 41(1):249-258. PubMed ID: 33419819
[TBL] [Abstract] [Full Text] [Related]
5. Primary uterine lymphoma: The Yokohama Cooperative Study Group for Hematology (YACHT) study.
Ishii Y; Fujisawa S; Ando T; Suzuki T; Ishiyama Y; Kishimoto K; Hattori Y; Nakajima Y; Miyazaki T; Takasaki H; Matsumoto K; Koharazawa H; Taguchi J; Fujimaki K; Sakai R; Nakajima H
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e455-e459. PubMed ID: 29984481
[TBL] [Abstract] [Full Text] [Related]
6. Primary diffuse large B cell lymphoma of the uterine cervix successfully treated by combined chemotherapy alone: A case report.
Cubo AM; Soto ZM; Cruz MÁ; Doyague MJ; Sancho V; Fraino A; Blanco Ó; Puig N; Alcoceba M; González M; Sayagués JM
Medicine (Baltimore); 2017 May; 96(19):e6846. PubMed ID: 28489772
[TBL] [Abstract] [Full Text] [Related]
7. The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
El-Galaly TC; Villa D; Michaelsen TY; Hutchings M; Mikhaeel NG; Savage KJ; Sehn LH; Barrington S; Hansen JW; Smith D; Rady K; Mylam KJ; Larsen TS; Holmberg S; Juul MB; Cordua S; Clausen MR; Jensen KB; Johnsen HE; Seymour JF; Connors JM; de Nully Brown P; Bøgsted M; Cheah CY
Eur J Cancer; 2017 Apr; 75():195-203. PubMed ID: 28237865
[TBL] [Abstract] [Full Text] [Related]
8. Primary diffuse large B-cell lymphoma of the uterus: case report and review.
Mandato VD; Palermo R; Falbo A; Capodanno I; Capodanno F; Gelli MC; Aguzzoli L; Abrate M; La Sala GB
Anticancer Res; 2014 Aug; 34(8):4377-90. PubMed ID: 25075075
[TBL] [Abstract] [Full Text] [Related]
9. Primary non-Hodgkin,s lymphoma of the uterine cervix.
Hanprasertpong J; Hanprasertpong T; Thammavichit T; Kongkabpan D; Tungsinmunkong K; Chandeying N
Asian Pac J Cancer Prev; 2008; 9(2):363-6. PubMed ID: 18712992
[TBL] [Abstract] [Full Text] [Related]
